Delphi consensus: First-line use of biologics and small molecules in hidradenitis suppurativa.
Nikolakis G, Alpsoy E, Anzengruber F, Augustin M, Bechara FG, Becherel PA, Benhadou F, Bettoli V, Cabete J, Caposiena Caro RD, Di Cesare A, Damiani G, Dini V, Giamarellos-Bourboulis EJ, Gáspár K, Glasenhardt K, Guillem P, Hafner A, Horvath B, Ingram JR, Jarienè V, Jemec GBE, Katoulis A, Kirsten N, Kokolakis G, Krajewski PK, Liakou AI, Manzo Margiotta F, Marzano AV, Martorell A, Matusiak L, Mintoff D, Molina Leyva A, Pinter A, Pirogova A, Podda M, Prignano F, Romani J, Romanelli M, Rosi E, Sahin S, Saunte DML, Schneider-Burrus S, Suppa M, Szepietowski J, Szegedi A, Thomsen SF, Tzellos T, Trigoni A, Van Der Zee HH, Van Straalen K, Valiukevičiene S, Vilarrasa E, von Stebut E, Zouboulis CC.
Nikolakis G, et al. Among authors: molina leyva a.
J Eur Acad Dermatol Venereol. 2026 Jan 24. doi: 10.1111/jdv.70264. Online ahead of print.
J Eur Acad Dermatol Venereol. 2026.
PMID: 41580305
Review.